Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Jan 25 | MRSN Mersana Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 0.58 | 4,514 | 2.62 k | 122,875 |
15 Jan 25 | MRSN Mersana Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 11,062 | 0.00 | 127,389 |
15 Jan 25 | MRSN Mersana Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 181,400 | 0.00 | 181,400 |
15 Jan 25 | MRSN Mersana Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.64 | 816,300 | 522.43 k | 816,300 |
15 Jan 25 | MRSN Mersana Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 11,062 | 0.00 | 33,188 |
12 Sep 24 | MRSN Mersana Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 1.76 | 50,423 | 88.74 k | 116,327 |
11 Sep 24 | MRSN Mersana Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 166,750 | 0.00 | 166,750 |
11 Sep 24 | MRSN Mersana Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 166,750 | 0.00 | 500,250 |
7 Feb 24 | SNDX Syndax Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 17,000 | 0.00 | 49,000 |
15 Jan 24 | MRSN Mersana Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 44,250 | 0.00 | 44,250 |